About Recues Biosciences
Recues Biosciences is a company based in Bengaluru (India) founded in 2018 by Vignesh Subramanian and Sridhar Haranahalli. It operates as a B2B. Recues Biosciences operates in a competitive market with competitors including Horizon Therapeutics, Kerecis, Osteal Therapeutics, Ilya Pharma and QBiotics, among others.
- Headquarter Bengaluru, India
- Founders Vignesh Subramanian, Sridhar Haranahalli
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Recues Biosciences Private Limited
- Date of Incorporation 28 Sep, 2018
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$41.77 K (USD)69.48as on Mar 31, 2022
-
Net Profit
-$1.46 K (USD)82.59as on Mar 31, 2022
-
EBITDA
$2.57 K (USD)171.48as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Recues Biosciences
Detailed funding history for Recues Biosciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Recues Biosciences
Investment portfolio details for Recues Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Recues Biosciences
Detailed financials for Recues Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Recues Biosciences Comparisons
Peer comparison for Recues Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Recues Biosciences
Recues Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Horizon Therapeutics, Kerecis, Osteal Therapeutics, Ilya Pharma and QBiotics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of drugs for treating rare and autoimmune diseases
|
|
| Locked | Locked | Locked |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| Locked | Locked | Locked |
Developer of pharmaceuticals for musculoskeletal therapeutics to treat orthopedic infections
|
|
| Locked | Locked | Locked |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| Locked | Locked | Locked |
Small molecules from plant extracts are developed for medical applications.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for bone regeneration are developed.
|
Detailed competitors of Recues Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Recues Biosciences
Complete news archive for Recues Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Recues Biosciences
Recues Biosciences was founded in 2018.
Recues Biosciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Annual revenue of Recues Biosciences is $41.77K as on Mar 31, 2022.
Recues Biosciences operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, regenerative medicine, and technology development. Develops innovative technologies in regenerative medicine for healthcare applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Recues Biosciences's top competitors include Horizon Therapeutics, Kerecis and Ilya Pharma.